Status:
COMPLETED
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
12+ years
Phase:
PHASE2
Brief Summary
The purpose of this trial is to determine the safety, efficacy and tolerability of two doses of the study drug compared to placebo for the treatment of subjects with seasonal allergic rhinitis.
Eligibility Criteria
Inclusion
- A documented history of seasonal allergic rhinitis to mountain cedar pollen
Exclusion
- Significant medical condition
- Cardiovascular abnormality
- Have a significant physical obstruction in the nose
- Started or had a change in immunotherapy within the 30 days prior to
- screening
- Have nasal ulceration(s) or any active nasal bleeding
- Require use of allergy medications during the study
- Require use of asthma medications other than as needed albuterol
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
571 Patients enrolled
Trial Details
Trial ID
NCT00407927
Start Date
December 1 2006
End Date
March 1 2007
Last Update
October 12 2015
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergy & Asthma Associates
Austin, Texas, United States, 78731
2
Lovelace Scientific Resources, Inc.
Austin, Texas, United States, 78759
3
Kerrville Research Associates
Kerrville, Texas, United States, 78028
4
Central Texas Health Research
New Braunfels, Texas, United States, 78130